{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:14:50Z","timestamp":1771002890373,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s53162","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T02:35:34Z","timestamp":1402626934000},"page":"853","source":"Crossref","is-referenced-by-count":15,"title":["Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus"],"prefix":"10.2147","author":[{"given":"Quang H.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,6]]},"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=20420","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:27:01Z","timestamp":1477852021000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/combination-of-brinzolamide-and-brimonidine-for-glaucoma-and-ocular-hy-peer-reviewed-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/ppa.s53162","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}